Altimmune to Participate at Two Upcoming Investor Conferences
May 29 2024 - 7:31AM
Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical
company, today announced that members of the Company’s management
team will participate and be available for 1x1 meetings at the
following investor conferences:
- Jefferies Global Healthcare Conference (New
York, NY)Wednesday, June 5, 2024Fireside Chat at 2:00 p.m. Eastern
Time
- Goldman Sachs Global Healthcare Conference
(Miami Beach, FL)Wednesday, June 12, 2024Fireside Chat at 9:20 a.m.
Eastern Time
The sessions will be webcast and can be accessed by visiting the
Events section of the Altimmune website.
About AltimmuneAltimmune is a clinical-stage
biopharmaceutical company focused on developing innovative
next-generation peptide-based therapeutics. The Company is
developing pemvidutide, a GLP-1/glucagon dual receptor agonist for
the treatment of obesity and MASH. For more information, please
visit www.altimmune.com.
Follow @Altimmune, Inc. on
LinkedInFollow @AltimmuneInc on
Twitter
Company Contact:Richard
Eisenstadt Chief
Financial Officer
Phone:
240-654-1450 ir@altimmune.com
Investor Contact:Lee RothBurns McClellanPhone:
646-382-3403lroth@burnsmc.com Julia WeilmanBurns McClellanPhone:
646-732-4443jweilman@burnsmc.com
Media Contact:Danielle CanteyInizio Evoke
CommsPhone: 619-826-4657Danielle.cantey@inizioevoke.com
Altimmune (NASDAQ:ALT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Altimmune (NASDAQ:ALT)
Historical Stock Chart
From Oct 2023 to Oct 2024